EUVIMEDEUVIMED entdecken
Crossref

Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota

Peng Jiang, Yun Zhang, Xiaojie Li, Junyang Chen iD

Phytotherapy Research · 2023-08 · 37 (8) · 3453-3466

DOI: 10.1002/ptr.7819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 26.04.2023. Verfasst von Peng Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Geniposidic acid (GPA) is a bioactive compound isolated from Gardenia jasminoides Ellis ( Rubiaceae ) that has long been used to treat arthritis, jaundice, and hypertension. However, the therapeutic effects of GPA against colitis remain underexplored. This study aimed to investigate the effect of GPA on the remission of colitis and the underlying mechanisms. A DSS‐induced colitis mouse model was used to evaluate the influence of GPA on the modulation of gut microbiota and intestinal epithelial barrier function. Our results indicated that GPA improved DSS‐induced mouse colitis, including loss of body weight, disease activity index (DAI), colon length, and colonic pathological damage. DSS‐induced destruction of the intestinal barrier was also significantly repaired by GPA treatment. In addition, the relative levels of pro‐inflammatory cytokines, such as IL‐1β and TNF‐α, were markedly alleviated by GPA. Furthermore, western blot analysis revealed that GPA downregulated the protein expression of the nuclear transcription factor NF‐κB. Finally, we first demonstrated that GPA could alleviate gut microbiota dysbiosis in mice with colitis by bacterial 16S rRNA sequencing. In conclusion, our study demonstrates the therapeutic and protective effects of GPA on IBD and provides novel insights into the prevention of colitis by targeting gut microbiota metabolism using natural products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisAnimalsMiceRNA, Ribosomal, 16SInflammationColonDisease Models, AnimalDextran SulfateMice, Inbred C57BLIridoid Glucosides

Stichwörter der Autor:innen

NF-κBgeniposidic acidgut microbiotainflammatory bowel diseaseintestinal barrier

Substanzen

RNA, Ribosomal, 16SDextran Sulfategeniposidic acidIridoid Glucosides

Autor:innen und Institutionen

  • Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • State Key Laboratory for Zoonotic Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun, China.
  • Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Department of Ophthalmology, Changchun People's Hospital, Changchun, China.

ORCID-Profile: Junyang Chen

Zitieren

APA

Jiang, P., Zhang, Y., Li, X., & Chen, J. (2023). Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota. Phytotherapy Research, 37(8), 3453-3466. https://doi.org/10.1002/ptr.7819

Vancouver

Jiang P, Zhang Y, Li X, Chen J. Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota. Phytotherapy Research. 2023;37(8):3453-3466. doi:10.1002/ptr.7819

BibTeX
@article{Jiang2023,
  author = {Jiang, Peng and Zhang, Yun and Li, Xiaojie and Chen, Junyang},
  title = {Geniposidic acid attenuates DSS ‐induced colitis through inhibiting inflammation and regulating gut microbiota},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {8},
  pages = {3453--3466},
  doi = {10.1002/ptr.7819}
}
Kostenlos starten →